Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acceptance and Commitment Therapy with Neuromyelitis Optica Spectrum Disorder Patient and Caregiver Pilot Study

NCT05840055 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT05840055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05840055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acceptance and Commitment Therapy with Neuromyelitis Optica Spectrum Disorder Patient and Caregiver Pilot Study
Lead sponsor
Thomas Jefferson University
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2023
Completion date
November 21, 2024
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nmo spectrum disorder